In this comparative study, Clapp et al. investigate the neural mechanisms underlying age-related decline in performance on tests of multitasking. A total of 20 older adults (mean age: 69; 65% female) and 22 younger adults (mean age: 25; 41% female) performed a delayed-recognition working memory task in which they were placed in a functional MRI scanner, shown an image of a natural landscape, then, after a brief delay, shown an interrupting or disrupting image of a face, and then a landscape matching or not matching the original. The participants were asked to state whether the second landscape matched or did not match the first. Other related trials were also performed as controls for the experimental condition. The performance of older adults on the working memory task was slower and less accurate than of younger adults in the presence of interrupting stimuli. Functional MRI data did not differ between age groups in the ability to process the interrupting stimulus, but demonstrated a significant impairment in older adults' ability to discontinue processing the interrupting stimulus and to reactivate the interrupted memory. In this nationally representative sample, household incomes under US$20,000 were associated with significantly higher odds of nearly all psychiatric diagnoses as compared with household incomes over $70,000. The highest odds ratios were for psychosis (4.28), bipolar disorder (2.56) and personality disorders (1.12-8.19 ).
Interestingly, low household income was
Journal Watch highlights some of the most important papers recently published in the field of neuropsychiatry and research. The editorial team welcomes recommendations for relevant papers for inclusion in future issues. Please direct your suggestions to: Jonathan Tee, Commissioning Editor j.tee@futuremedicine.com
NEWS & VIEWS jOUrNAl wAtCH
associated with reduced odds of alcohol use disorders (0.76). A decrease in income between the first and second waves of the study was associated with significantly higher odds of mood, anxiety or substance use disorders (1.3). Psychiatric diagnoses did not predict any changes in income between waves.
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In this multisite randomized controlled study, Essock et al. characterize the impact of switching from antipsychotic polypharmacy to monotherapy in a clinical pool of outpatients with schizophrenia or schizoaffective disorder. A total of 127 patients using two anti psychotic medications were randomized to continue their current regimen or to discontinue one of the medications in consultation with their study psychiatrist. The primary outcome was all-cause discontinuation at 6 months, with secondary outcomes of symptom level, hospital ization and side effects. At 6 months, 31% of patients randomized to monotherapy discontinued their assigned treatment, compared with 14% in the polypharmacy group. A total of 66% of patients discontinuing monotherapy returned to their original polypharmacy combination. In this group, the most frequent cause for discontinuation was symptom exacerbation (61%).
Of note, patients in the monotherapy arm had a mean reduction in BMI of 0.5 points while the poly pharmacy group had a mean increase in BMI of 0.3 points. This study adds important evidence to the ongoing assessment of risk versus benefit in antipsychotic polypharmacy to guide consumers, physicians and policymakers.
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